NASDAQ: SXTP
60 Degrees Pharmaceuticals Inc Stock Ownership - Who owns 60 Degrees Pharmaceuticals?

Insider buying vs selling

Have 60 Degrees Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Geoffrey S. DowPresident and CEO2026-06-127,350$1.38
$10.13kBuy
Geoffrey S. DowPresident and CEO2025-12-159,670$0.80
$7.76kBuy
Geoffrey S. DowPresident and CEO2025-12-113,613$0.92
$3.32kBuy
Geoffrey S. DowPresident and CEO2025-12-109,350$0.95
$8.88kBuy

1 of 1

SXTP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SXTP insiders and whales buy or sell their stock.

SXTP Shareholders

What type of owners hold 60 Degrees Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Knight Therapeutics Inc52.48%1,845,769$1.78MInsider
Geoffrey S. Dow19.97%702,393$677.81kInsider
Kentucky Technology Inc14.93%525,000$506.63kInsider
Florida State University Research Foundation Inc11.52%405,000$390.83kInsider
Tyrone Miller0.75%26,370$25.45kInsider
Cheryl Xu0.45%15,816$15.26kInsider
Charles W. Allen0.40%14,000$13.51kInsider
Stephen Toovey0.40%14,000$13.51kInsider
Paul Field0.40%14,000$13.51kInsider
Kristen Landon0.13%4,540$4.38kInsider

1 of 3

SXTP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SXTP0.01%99.99%Net Buying
EOCN0.02%21.22%
APVO0.00%100.00%Net BuyingNet Selling
MBIO0.01%13.37%Net Selling
CVKD0.00%28.17%Net Selling

60 Degrees Pharmaceuticals Stock Ownership FAQ

Who owns 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ: SXTP) is owned by 0.01% institutional shareholders, 101.42% 60 Degrees Pharmaceuticals insiders, and 0.00% retail investors. Knight Therapeutics Inc is the largest individual 60 Degrees Pharmaceuticals shareholder, owning 1.85M shares representing 52.48% of the company. Knight Therapeutics Inc's 60 Degrees Pharmaceuticals shares are currently valued at $1.69M.

If you're new to stock investing, here's how to buy 60 Degrees Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.